Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech research findings

SciBase Nevisense detects age-related skin changes

Analysis based on 9 articles · First reported May 18, 2026 · Last updated May 18, 2026

Sentiment
60
Attention
4
Articles
9
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The announcement of expanded applications for Nevisense>>> technology by SciBase>>> is likely to positively impact its stock price, as evidenced by the initial 3.37% increase. This development opens new market segments in geriatric dermatology and longevity science, potentially increasing SciBase>>>'s revenue streams and market valuation.

Medical Technology Dermatology Biotechnology

SciBase Holding AB announced new research findings at the Society for Investigative Dermatology Annual Meeting, highlighting the expanded potential of its Nevisense platform. The study, conducted by prof. Abuabara and Dr. Zhu at the University of California, San Francisco, demonstrated that SciBase's Electrical impedance spectroscopy (EIS) technology can successfully detect and quantify age-related changes in the skin barrier. This research expands Nevisense's application beyond melanoma detection and atopic dermatitis into geriatric dermatology and longevity science. The study identified 35 age-associated EIS features and developed a composite barrier score strongly correlated with age, indicating Nevisense's ability to detect subtle changes in skin architecture. Pia Renaudin, CEO of SciBase, emphasized the significance of these results for clinical dermatology and targeted skincare development. SciBase plans further validation to refine the composite barrier score for clinical and research use. SciBase's stock (SCIB.ST) saw an initial increase of 3.37% following the announcement.

100 SciBase announced research findings
stock
SciBase announced new research findings demonstrating expanded applications for its Nevisense technology, which could lead to new market opportunities and increased revenue. This positive development is reflected in its stock price increase.
Importance 100 Sentiment 70
oth
Nevisense, SciBase's proprietary platform, has shown expanded utility beyond melanoma detection to include age-related skin barrier changes, enhancing its market value and potential applications.
Importance 90 Sentiment 70
oth
Electrical impedance spectroscopy (EIS) is the core technology behind Nevisense, and its proven ability to detect age-related skin changes validates its versatility and potential for broader adoption.
Importance 80 Sentiment 60
per
Pia Renaudin, CEO of SciBase, expressed enthusiasm for the research findings, highlighting the strategic importance of the expanded applications for Nevisense.
Importance 60 Sentiment 50
priv
Carnegie Investment Bank AB (publ) is the Certified Adviser for SciBase, providing advisory services for its Nasdaq listing.
Importance 10 Sentiment 0
exch
SciBase is listed on the Nasdaq First North Premier Growth Market, which provides a platform for its stock trading.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.